Xing Yue, Hu Yangfan, Liu Xianwei, Ding Defang, Dai Shun, Lyu Liangjing, Zhang Guangcheng, Mao Shiqi, Yin Qian, Lu Junjie, Yang Jiarui, Song Yang, Zhang Huan, Li Chengzhou, Yao Weiwu, Zhong Jingyu
Department of Imaging, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
Shanghai Key Laboratory of Flexible Medical Robotics, Tongren Hospital, Institute of Medical Robotics, Shanghai Jiao Tong University, Shanghai, 200336, China.
Insights Imaging. 2025 Jul 17;16(1):155. doi: 10.1186/s13244-025-02040-3.
To evaluate the reproducibility and effectiveness of the Bone Reporting and Data System on MRI (Bone-RADS-MRI) for incidental solitary bone lesions in adults.
We retrospectively included 275 MRI cases from three local and two public databases, respectively. All the cases were histopathologically or clinically confirmed bone lesions, or "do not touch" lesions with typical appearance and remained stable for at least two years. Each lesion with gender, age, and clinical history was categorized according to the Bone-RADS algorithm by two musculoskeletal radiologists and two non-musculoskeletal radiologists. The Bone-RADS categories were as follows: Bone-RADS-1, likely benign, leave alone; Bone-RADS-2, incompletely assessed on imaging, perform different imaging modality; Bone-RADS-3, intermediate, perform follow-up imaging; Bone-RADS-4, suspicious for malignancy or need for treatment, biopsy and/or oncologic referral. Inter-reader agreement was evaluated. The diagnostic performance of the Bone-RADS-MRI was measured for distinguishing intermediate or malignant lesions or osteomyelitis from benign lesions. The histopathology results, clinical diagnosis, or follow-up were used as a standard reference.
There were 165 intermediate or malignant lesions or osteomyelitis, and 110 benign lesions, respectively. The inter-reader agreements between two musculoskeletal and between two non-musculoskeletal radiologists were both moderate (weighted kappa 0.572 and 0.520). The diagnostic performance for identifying intermediate or malignant lesions or osteomyelitis ranged according to radiologists with sensitivities of 88.5% to 94.5%, specificities of 55.5% to 74.5%, and accuracies of 76.4% to 82.9%.
Bone-RADS-MRI is effective for identifying bone lesions that need further treatment, but it has only moderate reliability for readers with different specialties and experience.
With local and public databases, Bone-RADS-MRI has been demonstrated to be a reliable algorithm for musculoskeletal and non-musculoskeletal radiologists with varying experience and an effective tool for identifying incidental solitary bone lesions that "need treatment" in adults.
Bone-RADS-MRI needs clinical validation for inter-reader agreement and diagnostic performance. Bone-RADS-MRI achieved moderate agreements between musculoskeletal and non-musculoskeletal radiologists, respectively. Bone-RADS-MRI presented high sensitivities but low specificities for identifying "need-for-treatment" bone lesions.
评估成人偶然发现的孤立性骨病变的骨报告与数据系统(Bone-RADS-MRI)的可重复性和有效性。
我们分别从三个本地数据库和两个公共数据库中回顾性纳入了275例MRI病例。所有病例均经组织病理学或临床确诊为骨病变,或为具有典型表现且至少两年保持稳定的“无需处理”病变。由两名肌肉骨骼放射科医生和两名非肌肉骨骼放射科医生根据Bone-RADS算法对每个具有性别、年龄和临床病史的病变进行分类。Bone-RADS分类如下:Bone-RADS-1,可能为良性,无需处理;Bone-RADS-2,影像学评估不完整,需进行不同的成像检查;Bone-RADS-3,中等程度,需进行随访成像;Bone-RADS-4,怀疑为恶性或需要治疗,需进行活检和/或转诊至肿瘤科。评估了阅片者间的一致性。测量了Bone-RADS-MRI区分中等程度或恶性病变或骨髓炎与良性病变的诊断性能。以组织病理学结果、临床诊断或随访结果作为标准参考。
分别有165例中等程度或恶性病变或骨髓炎以及110例良性病变。两名肌肉骨骼放射科医生之间以及两名非肌肉骨骼放射科医生之间的阅片者间一致性均为中等(加权kappa分别为0.572和0.520)。不同放射科医生识别中等程度或恶性病变或骨髓炎的诊断性能范围为:敏感性为88.5%至94.5%,特异性为55.5%至74.5%,准确性为76.4%至82.9%。
Bone-RADS-MRI对于识别需要进一步治疗的骨病变是有效的,但对于不同专业和经验的阅片者而言,其可靠性仅为中等。
利用本地和公共数据库,已证明Bone-RADS-MRI对于经验各异的肌肉骨骼和非肌肉骨骼放射科医生是一种可靠的算法,并且是识别成人偶然发现的“需要治疗”的孤立性骨病变的有效工具。
Bone-RADS-MRI的阅片者间一致性和诊断性能需要临床验证。Bone-RADS-MRI在肌肉骨骼和非肌肉骨骼放射科医生之间分别达成了中等程度的一致性。Bone-RADS-MRI在识别“需要治疗”的骨病变方面表现出高敏感性但低特异性。